HLVX HilleVax, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $0 on the open market.
HLVX revenue and earnings
- Quarter ended Jun 30, 2025: revenue n/a, net income −$5.27M, EPS -0.11
- Quarter ended Mar 31, 2025: revenue n/a, net income −$6.06M, EPS -0.12
- Quarter ended Dec 31, 2024: revenue n/a, net income −$33.9M, EPS -0.68
- Quarter ended Sep 30, 2024: revenue n/a, net income −$25.8M, EPS -0.52
Recent HLVX insider trades
- Feb 11, 2025: Hershberg Robert sold 26,535 shares ($48.6K)
- Feb 11, 2025: Maltbie Shane sold 8,291 shares ($15.1K)
Are insiders buying or selling HLVX?
No open-market insider buys or sells of HilleVax, Inc. were reported in the last 12 months.